MD-711 Phase 2/3 Study in Pulmonary Arterial Hypertension
Latest Information Update: 29 Sep 2022
Price :
$35 *
At a glance
- Drugs Treprostinil (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Mochida Pharmaceutical
- 23 Dec 2021 New trial record